21.03.2014 Views

Pricing architecture: the role of the NHSCB and Monitor in delivering ...

Pricing architecture: the role of the NHSCB and Monitor in delivering ...

Pricing architecture: the role of the NHSCB and Monitor in delivering ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Pric<strong>in</strong>g</strong> <strong>architecture</strong>: <strong>the</strong> <strong>role</strong> <strong>of</strong> <strong>the</strong><br />

<strong>NHSCB</strong> <strong>and</strong> <strong>Monitor</strong> <strong>in</strong> deliver<strong>in</strong>g<br />

payment reform<br />

Jason Mann – Transition Director for <strong>Pric<strong>in</strong>g</strong>, <strong>Monitor</strong><br />

John Holden – Director <strong>of</strong> Systems Policy, NHS CB<br />

17 January 2013


Current PbR: scope, currency, prices & rules all set by S<strong>of</strong>S<br />

Current<br />

Payment by<br />

Results<br />

Local tariffs<br />

Future<br />

Fixed national<br />

prices<br />

Local<br />

modifications<br />

Block<br />

contracts<br />

Department <strong>of</strong> Health<br />

Rules for prices not <strong>in</strong>cluded <strong>in</strong><br />

<strong>the</strong> National Tariff<br />

<strong>Monitor</strong> & NHS Commission<strong>in</strong>g Board<br />

• Under 2012 Act, <strong>Monitor</strong> & NHS CB share responsibility for pric<strong>in</strong>g from 2014/15<br />

• <strong>Pric<strong>in</strong>g</strong> more <strong>in</strong>dependent <strong>of</strong> politics but “double lock” on <strong>Monitor</strong> <strong>and</strong> NHS CB<br />

• Work<strong>in</strong>g toge<strong>the</strong>r on immediate plans for 2014/15 <strong>and</strong> medium/longer term vision<br />

2<br />

18 January<br />

2013


2012 Act sets out duties for <strong>Monitor</strong> <strong>and</strong> <strong>the</strong> NHS CB<br />

<strong>Monitor</strong> clauses<br />

General duties:<br />

• To protect <strong>and</strong> promote <strong>the</strong> <strong>in</strong>terests <strong>of</strong><br />

people who use health care services<br />

• To promote provision <strong>of</strong> health care services<br />

which is economic, efficient <strong>and</strong> effective<br />

• To ma<strong>in</strong>ta<strong>in</strong> or improve <strong>the</strong> quality <strong>of</strong> services<br />

• To enable <strong>in</strong>tegrated care<br />

<strong>Monitor</strong> must also have regard to:<br />

• Ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g patient safety<br />

• Desirable cont<strong>in</strong>uous improvement<br />

• Commission<strong>in</strong>g fair access to services based on<br />

cl<strong>in</strong>ical need <strong>and</strong> mak<strong>in</strong>g best use <strong>of</strong> resources<br />

• Providers cooperat<strong>in</strong>g to improve quality<br />

• Promot<strong>in</strong>g research<br />

• High st<strong>and</strong>ards for education <strong>and</strong> tra<strong>in</strong><strong>in</strong>g<br />

<strong>NHSCB</strong> clauses<br />

Requirements <strong>in</strong>clud<strong>in</strong>g:<br />

• To seek to achieve M<strong>and</strong>ate objectives<br />

• To have regard to NHS Constitution<br />

• To exercise its functions effectively,<br />

efficiently <strong>and</strong> economically<br />

• To exercise its functions with a view to<br />

secur<strong>in</strong>g cont<strong>in</strong>uous improvement <strong>in</strong> quality<br />

<strong>of</strong> services<br />

• To promote commissioner <strong>and</strong> provider<br />

autonomy<br />

• To reduce <strong>in</strong>equality<br />

• To promote patient <strong>in</strong>volvement <strong>and</strong> choice<br />

• To promote <strong>in</strong>novation<br />

• To promote <strong>in</strong>tegration<br />

3


Separate <strong>role</strong>s, jo<strong>in</strong>t responsibility…<br />

NHS CB will lead on:<br />

• Scope <strong>and</strong> design <strong>of</strong><br />

currencies<br />

• Variation rules to National<br />

Tariff currencies<br />

Close work<strong>in</strong>g<br />

<strong>and</strong> agreement<br />

<strong>Monitor</strong> will lead on:<br />

• <strong>Pric<strong>in</strong>g</strong> methodology<br />

• Regulated prices<br />

• Local modifications<br />

• Rules for local pric<strong>in</strong>g <strong>and</strong><br />

non-tariff pric<strong>in</strong>g<br />

6 shared pr<strong>in</strong>ciples for pric<strong>in</strong>g<br />

1. Enable <strong>and</strong> promote improvements <strong>in</strong> care for patients <strong>and</strong> taxpayers<br />

2. Enable an efficient provider to earn appropriate reimbursement for <strong>the</strong>ir services<br />

3. Have regard to susta<strong>in</strong><strong>in</strong>g <strong>the</strong> NHS <strong>of</strong>fer <strong>in</strong> <strong>the</strong> long run (taxpayer funded health service, universal <strong>and</strong><br />

comprehensive based on cl<strong>in</strong>ical need, not ability to pay)<br />

4. Not preclude <strong>the</strong> delivery <strong>of</strong> <strong>the</strong> Secretary <strong>of</strong> State’s M<strong>and</strong>ate for <strong>the</strong> <strong>NHSCB</strong><br />

5. Have regard to <strong>the</strong> pr<strong>in</strong>ciples <strong>of</strong> better regulation<br />

6. Support movement towards a fair play<strong>in</strong>g field for providers<br />

Currently develop<strong>in</strong>g partnership agreement between <strong>Monitor</strong> <strong>and</strong> <strong>NHSCB</strong>…<br />

….pric<strong>in</strong>g is only one <strong>of</strong> many elements.<br />

4<br />

18 January<br />

2013


We recognise <strong>the</strong> challenges fac<strong>in</strong>g <strong>the</strong> NHS…<br />

• The NHS will be fac<strong>in</strong>g unprecedented challenges <strong>in</strong> <strong>the</strong> upcom<strong>in</strong>g years:<br />

f<strong>in</strong>ancial, demographic <strong>and</strong> epidemiological<br />

• We know we need a system that can respond to <strong>the</strong> new dem<strong>and</strong>s <strong>of</strong><br />

multi-morbidity, chronic conditions <strong>and</strong> better patient experiences<br />

• S<strong>in</strong>ce its <strong>in</strong>troduction <strong>in</strong> 2004, <strong>the</strong> tariff has been <strong>the</strong> subject <strong>of</strong> much<br />

debate <strong>and</strong> <strong>the</strong> objectives it was designed to achieve have evolved <strong>in</strong> <strong>the</strong><br />

past 8 years<br />

• It is a tool that has faced both criticism <strong>and</strong> admiration, <strong>and</strong> has become<br />

(perhaps overly) focused upon as a solution to a wide-range <strong>of</strong> issues,<br />

from wait<strong>in</strong>g times to choice, system re-design <strong>and</strong> f<strong>in</strong>ancial viability<br />

• The NHS CB <strong>and</strong> <strong>Monitor</strong> have a unique opportunity as new<br />

organisations with jo<strong>in</strong>t-responsibility for tariff, to undertake some strategic<br />

th<strong>in</strong>k<strong>in</strong>g on this fundamental national lever<br />

5


Our approach so far….<br />

1<br />

Sector<br />

Engagement<br />

& Evaluation<br />

• Extensive stakeholder engagement through <strong>in</strong>terviews <strong>and</strong> workshops,<br />

<strong>in</strong>clud<strong>in</strong>g with <strong>in</strong>ternational experts <strong>and</strong> academics<br />

• Research to underst<strong>and</strong> <strong>the</strong> strengths <strong>and</strong> weaknesses <strong>of</strong> <strong>the</strong> current system<br />

(see <strong>Monitor</strong>’s website for <strong>the</strong> Evaluation)<br />

2<br />

Improv<strong>in</strong>g<br />

cost<strong>in</strong>g<br />

• Clear consensus on need for better <strong>in</strong>formation –particularly on cost<strong>in</strong>g<br />

• Therefore started already – driven also by long time lag between collection <strong>and</strong><br />

publication<br />

3<br />

2014/2015<br />

Policy<br />

Decisions<br />

• 2014/15 is <strong>Monitor</strong> <strong>and</strong> <strong>NHSCB</strong>’s first National Tariff Document<br />

• Under new legal framework we are obliged to consult formally…<br />

…so publication will be earlier than previously (<strong>and</strong> start with <strong>in</strong>formal<br />

consultation, as per “sense-check” today, <strong>in</strong> June)<br />

4<br />

6<br />

Long Run<br />

Strategy for<br />

<strong>Pric<strong>in</strong>g</strong><br />

• A long-run strategy for pric<strong>in</strong>g will anchor NHS CB <strong>and</strong> <strong>Monitor</strong>’s pric<strong>in</strong>g policy<br />

research, development <strong>and</strong> decision-mak<strong>in</strong>g<br />

• Work has started, tak<strong>in</strong>g <strong>in</strong>to account sector feedback <strong>and</strong> evaluations <strong>of</strong> PbR,<br />

<strong>and</strong> will need to align to our overall corporate strategies


Emerg<strong>in</strong>g <strong>the</strong>mes from stakeholder discussions to date<br />

Theme<br />

Outcomes<br />

focused<br />

Sett<strong>in</strong>g<br />

neutral<br />

Key messages/issues<br />

• Commission<strong>in</strong>g for outcomes: what do cl<strong>in</strong>icians & patients believe will make<br />

a difference?<br />

• Outcomes → develop service model → identify barriers → align <strong>in</strong>centives →<br />

allow flexibility<br />

• Outcome must be evidence based<br />

• Achievement <strong>of</strong> outcomes across range <strong>of</strong> sett<strong>in</strong>gs → co-ord<strong>in</strong>ated or<br />

<strong>in</strong>tegrated care <strong>and</strong> support<br />

• Need to promote efficient function<strong>in</strong>g <strong>of</strong> cl<strong>in</strong>ical networks <strong>and</strong> specialist care<br />

• Consider <strong>in</strong>terface between CCG & NHS CB commissioned services (e.g.,<br />

primary care)<br />

Flexibility • One size payment structure/mechanism will not fit all types <strong>of</strong> care<br />

• Promote local flexibilities to enable <strong>in</strong>novation<br />

• National st<strong>and</strong>ard or guidel<strong>in</strong>es can provide framework for flexibilities<br />

7


Emerg<strong>in</strong>g <strong>the</strong>mes from stakeholder discussions to date<br />

Theme<br />

Manage Sector<br />

Transition<br />

Classification<br />

<strong>of</strong> patients<br />

Key messages/issues<br />

• Need to ensure pric<strong>in</strong>g does not impede change <strong>and</strong> creates<br />

appropriate <strong>in</strong>centives (sounds obvious, but..)<br />

• Longer contract<strong>in</strong>g <strong>and</strong> pric<strong>in</strong>g periods to encourage <strong>in</strong>novation <strong>and</strong><br />

<strong>in</strong>vestment<br />

• Managed processes for shift <strong>in</strong> services between sett<strong>in</strong>gs<br />

• Reflects patient needs over longer term ra<strong>the</strong>r <strong>the</strong>n piecemeal<br />

approach to pric<strong>in</strong>g<br />

• Improved coverage <strong>of</strong> co-morbidities<br />

Data • Need to improve data quality….<br />

• …but recognise trade-<strong>of</strong>f with burden <strong>of</strong> data collection on providers<br />

<strong>Pric<strong>in</strong>g</strong> – only<br />

one lever<br />

• <strong>Pric<strong>in</strong>g</strong> is one lever for change…<br />

• …also cl<strong>in</strong>ical guidel<strong>in</strong>es, st<strong>and</strong>ards, more <strong>in</strong>formation to patient,<br />

competition, benchmark<strong>in</strong>g, support, education...<br />

8


<strong>Monitor</strong> has published a strategy for improv<strong>in</strong>g cost<strong>in</strong>g<br />

Cost<strong>in</strong>g Framework Status quo <strong>and</strong> issues Key recommendations<br />

Methodology<br />

Cost allocation st<strong>and</strong>ards for<br />

providers <strong>and</strong> cost<strong>in</strong>g system<br />

requirements<br />

Only a m<strong>in</strong>imum st<strong>and</strong>ard<br />

<strong>of</strong> allocation is m<strong>and</strong>atory<br />

Cost<strong>in</strong>g systems <strong>and</strong><br />

allocation approaches vary<br />

across providers<br />

Develop a s<strong>in</strong>gle<br />

st<strong>and</strong>ardised methodology,<br />

build<strong>in</strong>g on <strong>the</strong> HFMA’s<br />

cost<strong>in</strong>g st<strong>and</strong>ards<br />

Work with key<br />

stakeholders to develop<br />

<strong>the</strong>se st<strong>and</strong>ards<br />

Collection<br />

Who to collect data from,<br />

what should be collected <strong>and</strong><br />

how frequently<br />

The majority <strong>of</strong> NHS<br />

providers submit average<br />

cost by HRG,<br />

supplemented by ad hoc<br />

patient level collections<br />

Collect patient level data<br />

from a sample <strong>of</strong> providers<br />

with st<strong>and</strong>ardised<br />

methodology<br />

In <strong>the</strong> meantime, cont<strong>in</strong>ue<br />

to collect reference costs<br />

until sample data is robust<br />

9<br />

Assurance<br />

Assurance processes around<br />

cost methodology <strong>and</strong><br />

collection<br />

Despite a retrospective<br />

review <strong>of</strong> Reference Costs<br />

<strong>in</strong> 2011, <strong>in</strong> some areas <strong>of</strong><br />

<strong>the</strong> cost<strong>in</strong>g process <strong>the</strong>re<br />

is a lack <strong>of</strong> assurance<br />

Use peer group reviews,<br />

self assessment tools <strong>and</strong><br />

checklists to improve<br />

assurance over cost<strong>in</strong>g<br />

methodology<br />

Carry out targeted external<br />

assurance


So – <strong>in</strong> 2014/15 – our first National Tariff…<br />

Our first National Tariff is an opportunity to signal priorities <strong>and</strong> a direction <strong>of</strong> travel.<br />

But we need balance…<br />

Change<br />

Urgent <strong>and</strong> important<br />

issues<br />

Cl<strong>in</strong>ically driven<br />

change focussed on<br />

outcomes<br />

Managed shift <strong>in</strong> legal<br />

accountability<br />

M<strong>in</strong>imise undue price<br />

volatility<br />

Stability<br />

We expect to outl<strong>in</strong>e plans for 2014/15 <strong>in</strong> April ‘13 – earlier notification than<br />

previously possible – <strong>and</strong> to re<strong>in</strong>force flexibilities <strong>in</strong> current PbR rules <strong>and</strong> guidance.<br />

10


Our pric<strong>in</strong>g strategy for <strong>the</strong> medium to long-run…<br />

One size doesn’t fit all <strong>in</strong> pric<strong>in</strong>g<br />

But it is anchored around value<br />

We are consider<strong>in</strong>g<br />

• Different types <strong>of</strong> healthcare<br />

services or patient groups<br />

• different types <strong>of</strong> pric<strong>in</strong>g<br />

approaches<br />

• Balance <strong>of</strong> national direction vs.<br />

local flexibility<br />

… while try<strong>in</strong>g to establish a<br />

coherent <strong>and</strong> transparent<br />

regulatory framework<br />

Act sets out clear legal duties for<br />

<strong>Monitor</strong> <strong>and</strong> NHS CB<br />

Our focus for <strong>the</strong> long-run strategy<br />

will be how pric<strong>in</strong>g can:<br />

• Improve quality <strong>of</strong> care for<br />

patients – outcomes <strong>and</strong><br />

experiences; <strong>and</strong><br />

• Improve efficiency/ reduce costs<br />

… <strong>the</strong>reby promot<strong>in</strong>g value for<br />

patients today <strong>and</strong> tomorrow<br />

11


From April we will seek sector feedback on our proposals<br />

April June September<br />

Long Run<br />

Vision for<br />

<strong>Pric<strong>in</strong>g</strong> <strong>and</strong><br />

Implications for<br />

pric<strong>in</strong>g <strong>in</strong><br />

2014/15<br />

12<br />

Sector<br />

engagement<br />

on Long Run<br />

Vision<br />

Informal<br />

consultation<br />

(“Sensecheck”)<br />

on<br />

2014/15 NTD<br />

Formal<br />

consultation on<br />

2014/15 NTD<br />

Long-Run<br />

Strategy for<br />

<strong>Pric<strong>in</strong>g</strong><br />

[date tbc]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!